CatSci

27.06.2024 • News

CatSci Acquires Chromatography Provider Reach Separations

In a move to enhance its chemistry, manufacturing and controls (CMC) capabilities, UK-based process research and development contract research organization (CRO) CatSci has acquired chromatography provider Reach Separations. Financial details of the transaction were not disclosed.

20.04.2020 • Topics • Strategy

Chemical Process Research and Development

05.09.2019 • Topics • Strategy

Experts Statements: João Madeira, CatSci

05.09.2019 • Topics • Strategy

The Pharma CDMO Challenge

23.05.2019 • News

CatSci Appoints two Business Development Managers

19.09.2018 • Topics • Technology

M&A in Pharma and CRO/CMO Industry

28.06.2018 • News

CatSci Appoints Paul Bradley as Head of Business Development

Top-Feature

Bio-Rad Laboratories

Dual‑Targeting Breakthroughs: Advancements in Bispecific Antibody Development

Nova-Institut GmbH

Advanced Recycling Conference 2025: New Paths to the Circular Economy

Evonik Operations GmbH (Hanau)

Biobased Feedstocks as a Roadmap to Defossilization

Interview

Strategic Response to a Shifting Pharma Landscape

Stability in Motion

Stefan Oelrich, Member of the Board of Management and President Pharmaceuticals, Bayer, discusses navigating external volatility, reshaping its internal structures, and investing in future-ready capabilities to ensure sustainable growth.

CatSci Ltd.